<SEC-DOCUMENT>0001104659-20-116128-index.html : 20201019 <SEC-HEADER>0001104659-20-116128.hdr.sgml : 20201019 <ACCEPTANCE-DATETIME>20201019170912 ACCESSION NUMBER: 0001104659-20-116128 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20201019 DATE AS OF CHANGE: 20201019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-249550 FILM NUMBER: 201246757 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 </SEC-HEADER> <DOCUMENT> <TYPE>S-1 <SEQUENCE>1 <FILENAME>tm2033419d1_s1.htm <DESCRIPTION>FORM S-1 <TEXT> Document 1 - file: tm2033419d1_s1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>tm2033419d1_ex1-1.htm <DESCRIPTION>EXHIBIT 1.1 <TEXT> Document 2 - file: tm2033419d1_ex1-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.10 <SEQUENCE>3 <FILENAME>tm2033419d1_ex4-10.htm <DESCRIPTION>EXHIBIT 4.10 <TEXT> Document 3 - file: tm2033419d1_ex4-10.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>4 <FILENAME>tm2033419d1_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 4 - file: tm2033419d1_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>5 <FILENAME>tm2033419d1_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 5 - file: tm2033419d1_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>tm20334119d1_ex5-1img.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: tm20334119d1_ex5-1img.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>tm2033419-1_s1img01.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: tm2033419-1_s1img01.jpg
</DOCUMENT> </SEC-DOCUMENT>